Janssen Scientific Affairs, 1125 Trenton Harbourton Rd, Titusville, NJ, 08560, USA.
Gilead Sciences, Foster City, CA, USA.
Ther Innov Regul Sci. 2020 Nov;54(6):1275-1281. doi: 10.1007/s43441-020-00162-y. Epub 2020 May 23.
A benchmarking survey was conducted by the pharmaceutical collaboration for transparent Medical Information (phactMI™) consortium, with the goal to capture insights from the 27 member companies and their medical information organizations.
phactMI™ Benchmarking Committee delivered an electronic survey to 27 United States (US) member companies' Medical Information (MI) departments between December 12, 2017 and February 20, 2018. The survey consisted of approximately 300 questions, divided into 9 topics which included multiple choice and open-ended questions about the following categories: medical information support provided based on different product lifecycles, key metrics measured to assess department performance, and other key services provided by medical information groups.
The extent of MI product support varied across the lifecycle of a product. Most companies provided MI product support throughout the product lifecycle starting from investigational all the way through mature; however, the extent of activities varied. The top key performance indicators (KPIs) that were reported to senior leadership included response turnaround time (59%) and inquiry volume (48%). Among the 27 companies, 85% noted using customer satisfaction surveys administered via links within written response documents and 52% verbally via the company's call center. Other services with which MI groups noted most involvement included congress booth support (100%), insights/metric reporting (96%), and training the sales force on the MI function (74%). Additional services included payor support clinical pathway submissions (22%), presenting at advisory boards (22%), and competitive intelligence (26%).
The results of this survey provide pharmaceutical MI groups with opportunities to consider services or activities that could enhance the support these groups provide to their customers and business partners.
制药行业透明医学信息合作组织（phactMI™）开展了基准调查，旨在从 27 家成员公司及其医学信息组织中收集相关信息。
phactMI™基准委员会于 2017 年 12 月 12 日至 2018 年 2 月 20 日向 27 家美国成员公司的医学信息（MI）部门发送了一份电子调查问卷。该调查共包含约 300 个问题，分为 9 个主题，包括基于不同产品生命周期的医学信息支持、评估部门绩效的关键指标，以及医学信息组提供的其他关键服务等方面的多项选择题和开放式问题。
MI 产品支持的范围因产品生命周期而异。大多数公司在产品生命周期的各个阶段都提供 MI 产品支持，从研究阶段到成熟阶段；然而，活动的范围有所不同。向高级领导层报告的顶级关键绩效指标（KPI）包括响应周转时间（59%）和查询量（48%）。在 27 家公司中，85%的公司表示使用通过书面回复文档中的链接进行的客户满意度调查，52%的公司通过公司的呼叫中心进行口头调查。MI 组表示最常涉及的其他服务包括参展支持（100%）、见解/指标报告（96%）以及对销售团队进行 MI 职能培训（74%）。其他服务包括向支付方提供临床路径提交、参加顾问委员会以及竞争情报（26%）。
这项调查的结果为制药公司的 MI 团队提供了机会，以考虑可能增强这些团队向其客户和业务伙伴提供支持的服务或活动。
